Eden Research has reported preliminary results for the 12-months to 31 December 2021. The company has reported product sales of approximately £1.1m, as per the recent trading update, flat YoY but up 6% at constant exchange rates (CER). EBITDA loss was £2.0m and Eden closed the year with a cash position of £3.9m. The company notes positive progress through the year, highlighting the development of its Corteva agreement and expansion of the addressable markets for its launched products, Mevalone a ....
31 May 2022
Cenkos: Eden Research Plc -- Preliminary results – positive progress
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Eden Research Plc -- Preliminary results – positive progress
Eden Research plc (EDEN:LON) | 4.8 0 0.0% | Mkt Cap: 25.9m
- Published:
31 May 2022 -
Author:
Chris Donnellan -
Pages:
7
Eden Research has reported preliminary results for the 12-months to 31 December 2021. The company has reported product sales of approximately £1.1m, as per the recent trading update, flat YoY but up 6% at constant exchange rates (CER). EBITDA loss was £2.0m and Eden closed the year with a cash position of £3.9m. The company notes positive progress through the year, highlighting the development of its Corteva agreement and expansion of the addressable markets for its launched products, Mevalone a ....